X @Bloomberg
AbbVie(US:ABBV) Bloomberg·2025-08-25 14:40Deals & Acquisitions - AbbVie to acquire experimental depression treatment from Gilgamesh Pharmaceuticals Inc for up to $12 亿 (billion) [1] Industry Trends - Drug industry shows growing interest in next-generation psychedelic compounds [1]